Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.43 |
| ▸ | SUMO2 | P61956 | 4/20 | 0.43 |
| ▸ | SUMO1 | P63165 | 4/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 4/20 | 0.43 |
| ▸ | SENP2 | Q9HC62 | 4/20 | 0.43 |
| ▸ | ATIC | P31939 | 2/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 6/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17280514 | 1.00 | TP53 (0.43) | TP53BRD4CREBBPSUMO2SUMO1 | |
| SCHEMBL17280523 | 0.93 | ENPP2 (0.48) | TP53BRD4CREBBPSUMO2SUMO1 | |
| SCHEMBL17280504 | 0.91 | SENP2 (0.49) | TP53BRD4CREBBPSUMO2SUMO1 | |
| SCHEMBL17280515 | 0.91 | SENP2 (0.49) | TP53BRD4CREBBPSUMO2SUMO1 | |
| SCHEMBL17280507 | 0.91 | SENP2 (0.49) | TP53BRD4CREBBPSUMO2SUMO1 | |
| SCHEMBL12054251 | 0.89 | ENPP2 (0.44) | TP53BRD4CREBBPSUMO2SUMO1 | |
| SCHEMBL19958122 | 0.89 | ENPP2 (0.48) | TP53BRD4CREBBPSUMO2SUMO1 | |
| SCHEMBL17460971 | 0.87 | ENPP2 (0.47) | TP53BRD4CREBBPSUMO2SUMO1 | |
| SCHEMBL17283957 | 0.87 | ENPP2 (0.47) | TP53BRD4CREBBPSUMO2SUMO1 | |
| SCHEMBL19958121 | 0.85 | ENPP2 (0.52) | TP53BRD4CREBBPSUMO2SUMO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9341747-B2 | Azo compound and salt thereof, and dye-based polarizing film and polarizing plate containing the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2016-05-17 | — | — | US | disclosed |
| US-20160103362-A1 | Azo Compound and Salt Thereof, And Dye-Based Polarizing Film And Polarizing Plate Containing The Same | POLATECHNO CO LTD (JP) | 2016-04-14 | — | — | US | disclosed |
| US-9244194-B2 | Azo compound and salt thereof, and dye-based polarizing film and polarizing plate containing the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2016-01-26 | — | — | US | disclosed |
| US-20150337134-A1 | Azo Compound And Salt Thereof, And Dye-Based Polarizing Film And Polarizing Plate Containing The Same | NIPPON KAYAKU KK (JP) | 2015-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160103362-A1 | Azo Compound and Salt Thereof, And Dye-Based Polarizing Film And Polarizing Plate Containing The Same | TYR, CRY1, NAP1L4 | TP53 1854/4885BRD4 187/4885CREBBP 2719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.